What is Phorm?
Phorm operates as a sophisticated global personalisation technology firm, bridging the gap between Internet Service Providers (ISPs) and the digital advertising landscape. By leveraging innovative, privacy-centric platforms, the company enhances the browsing experience for end-users while providing publishers and advertisers with highly relevant, data-driven engagement tools. Its core value proposition lies in its ability to integrate seamlessly with fixed and wireless ISP infrastructures, effectively transforming standard web navigation into a tailored, high-value digital environment. This unique positioning allows Phorm to serve as a critical intermediary in the ad-tech value chain, facilitating more efficient content delivery and improved monetization strategies for its diverse network of partners.
How much funding has Phorm raised?
Phorm has raised a total of $93.2M across 4 funding rounds:
Series A
$65M
Series B
$24M
Private Equity
$3.2M
Private Equity
$1M
Series A (2008): $65M with participation from Canaccord Genuity Inc and Morgan Stanley & Co.
Series B (2009): $24M led by Mirabaud Securities
Private Equity (2015): $3.2M, investors not publicly disclosed
Private Equity (2016): $1M, investors not publicly disclosed
Key Investors in Phorm
Canaccord Genuity Inc
Genuity Group is an independent, full-service financial services firm, with operations in two principal segments of the securities industry: wealth management and capital markets. It was established in 1950, and is headquartered in Vancouver, British Columbia.
Morgan Stanley & Co.
Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services.
Mirabaud Securities
Founded in 1819, Mirabaud Securities is a wealth management company that offers asset management, investment advice, wealth planning, and corporate advisory services.
What's next for Phorm?
With the recent infusion of capital, Phorm is positioned to accelerate its enterprise-level growth initiatives. The strategic focus will likely shift toward deepening integration with global ISP partners and refining its personalisation algorithms to meet evolving privacy standards. As the digital advertising market continues to prioritize user-centric relevance, Phorm's ability to scale its technology stack will be pivotal. Future growth will depend on the firm's capacity to maintain its competitive edge in the ad-tech sector while navigating the regulatory complexities inherent in global data processing and consumer personalisation.
See full Phorm company page